secwatch.observer — SEC 8-K summary
======================================

Issuer:     Akari Therapeutics Plc (AKTX)
CIK:        0001541157
Form:       8-K
Filed at:   2025-08-19T23:59:59+00:00
Accession:  0001641172-25-024732
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Akari Therapeutics posts updated investor presentation; details not disclosed
-----------------------------------------------------------------------------

- Company furnished an updated corporate presentation as Exhibit 99.1 on Form 8-K.
- Presentation will be used in meetings but no specific financial or strategic updates provided.
- No new material information available beyond the filing itself.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1541157/000164117225024732/0001641172-25-024732-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1541157/000164117225024732/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-024732

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer